John B Rush


John was appointed as CEO of Lombard Medical on 12 October 2009.  Before joining Lombard John was President and CEO of North American Scientific, Inc. (NASDAQ: NASM).  He re-organized the Company and led an investor group initiative to take the Company private.  The new organization is focused on commercializing temporary implants for local radiation delivery.  John was also President and CEO of MicroTherapuetics, Inc (NASDAQ:MTIX), an interventional neuroradiology company with operations in US and Europe.  He orchestrated a successful sale of the company to ev3.  Prior to MTIX, John spent 10 years with Scimed Life Systems/Boston Scientific in various management roles, including General Manager of Boston Scientific’s  Asia Pacific business based in Singapore.  John has extensive domestic and international experience, with a core sales and marketing background.